At what cost? Paying the price for the market in the English NHS

Calum Paton | February 17, 2014 | Analyses

This analysis looks at the evidence showing that creating and maintaining markets in the NHS has incurred huge financial costs and significant ‘opportunity costs’ – money which could have spent upon patient care and clinical redesign. The analysis goes on to argue that it is possible for the NHS to offer patient choice and high-quality health-care without the market.

At what cost? Paying the price for the market in the English NHS

Support Our Work

CHPI is the only truly independent health think-tank dedicated to the founding principles of the NHS. To continue our work keeping the public interest at the centre of health and social care policy, we need your help.

Please support CHPI so we can continue to impact the health policy debate.

About the author


Calum Paton

Calum Paton is now Professor of Public Policy at Keele University, where he has been Professor of Health Policy since 1993. He has written many books and articles on politics and health policy, and has researched 'reforms' to the UK (later, English) NHS since the late 1980s. He has also led EU research projects on health system reform and researched US health policy. He is Editor-in-Chief of the International Journal of Health Planning and Management (Wiley Blackwell). He is a regular national media commentator. He has been a witness to the House of Commons Select Committee on Health and to the Francis Public Inquiry. He has recently advised WHO and the Health Bureau of Shanghai-Pudong in the PRChina as the latest of long-standing international commitments. He was Chair of the University Hospital of North Staffordshire NHS Trust from 2000-2006. At Keele, he is the long-serving Director of the MBA Health Executive programme.See all posts by Calum Paton